III session icon

Resolution Pharmacology – new therapeutic approaches for the treatment of inflammatory diseases

  • Chair(s):

    Patrícia Silva,
    Researcher in Public Health, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil

    Mauro Perretti,
    Professor, Queen Mary University of London, London, United Kingdom

  • Session description:

    Development of FPR2 small molecules to treat heart failure: from preclinical to phase I trial
    Dr Ricardo Garcia
    Sr. Principal Scientist, Bristol-Myers Squibb Co., Princeton, NJ, The United States of America

    Advances in antifibrotic therapies for chronic lung diseases
    Dr Patrícia Silva
    Senior Researcher in Public Health, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil

    Oral communication speaker - to be confirmed in 2023.

    The Annexin A1 mimetic RTP-026 regulates the immune response to elicit protection in myocardial infarction
    Dr Mauro Perretti
    Professor, Queen Mary University of London, United Kingdom

    AP1189: a biased agonist for melanocortin receptors in Phase IIa
    Professor Thomas Jonassen
    Syn Act Pharma, Holt, Denmark

Date

04 Jul 2023
Expired!

Time

9:45 am - 12:10 pm

Speakers

Leave A Comment

Go to Top